These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7804463)
21. Opportunities and challenges for the development of antisense treatment in neuromuscular disorders. van Putten M; Aartsma-Rus A Expert Opin Biol Ther; 2011 Aug; 11(8):1025-37. PubMed ID: 21510827 [TBL] [Abstract][Full Text] [Related]
22. The 5th National Colloquium on Neuromuscular Diseases. Strasbourg, 21-25 June 1993. Mandel JL Neuromuscul Disord; 1993; 3(5-6):353-9. PubMed ID: 8186675 [No Abstract] [Full Text] [Related]
24. Myogenic conversion of human non-muscle cells for the diagnosis and therapy of neuromuscular diseases. Miranda AF; Mongini T; Bonilla E; Miller AD; Wright WE Adv Exp Med Biol; 1990; 280():205-10. PubMed ID: 2248140 [No Abstract] [Full Text] [Related]
27. [NeuroMyoGene Institute: a Franco-Canadian partnership promoting research in neuromuscular disorders]. Schaeffer L Med Sci (Paris); 2016 Nov; 32 Hors série n°2():55-56. PubMed ID: 27869078 [No Abstract] [Full Text] [Related]
28. [Neuromuscular diseases. Molecular genetic methods will revolutionize diagnosis and treatment]. Anvret M; Edström L; Ahlberg G Lakartidningen; 1992 Mar; 89(11):862, 865-9. PubMed ID: 1545641 [No Abstract] [Full Text] [Related]
29. Current methodological issues in the study of children with inherited neuromuscular disorders. Mercuri E; Messina S; Pane M; Bertini E Dev Med Child Neurol; 2008 Jun; 50(6):417-21. PubMed ID: 18430158 [TBL] [Abstract][Full Text] [Related]
30. 4th Colloquium on Neuromuscular Diseases (24-28 June 1991, Montpellier, France). Schwartz K Neuromuscul Disord; 1991; 1(4):299-304. PubMed ID: 1822809 [No Abstract] [Full Text] [Related]
31. RNA-targeting approaches for neuromuscular diseases. Le Roy F; Charton K; Lorson CL; Richard I Trends Mol Med; 2009 Dec; 15(12):580-91. PubMed ID: 19906562 [TBL] [Abstract][Full Text] [Related]
32. Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials. Kley RA; Tarnopolsky MA; Vorgerd M J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):366-7. PubMed ID: 18344391 [No Abstract] [Full Text] [Related]
33. Systematic reviews to help guide clinical practice in neuromuscular disease. Jewitt K; Hughes R J Neurol Neurosurg Psychiatry; 2003 Jun; 74 Suppl 2(Suppl 2):ii43-ii44. PubMed ID: 12754329 [No Abstract] [Full Text] [Related]
35. [Organization of therapeutic aid to patients with hereditary neuromuscular diseases]. Kalinin VA; Temin PA; Arkhipov BA; Zavadenko NN Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):26-9. PubMed ID: 2633564 [TBL] [Abstract][Full Text] [Related]
37. Neuromuscular diseases rehabilitation in the era of gene therapy. Trabacca A Neurol Sci; 2020 Jul; 41(7):1971-1972. PubMed ID: 32034556 [No Abstract] [Full Text] [Related]
38. Diagnostic histochemistry and clinical-pathological testings as molecular pathways to pathogenesis and treatment of the ageing neuromuscular system: a personal view. Engel WK Biochim Biophys Acta; 2015 Apr; 1852(4):563-84. PubMed ID: 25460198 [TBL] [Abstract][Full Text] [Related]
39. Gene transfer to muscle. Dickson G Biochem Soc Trans; 1996 May; 24(2):514-9. PubMed ID: 8736795 [No Abstract] [Full Text] [Related]